Oxford Nanopore reports 28% revenue growth in first half of 2025

Published 21/07/2025, 07:26
Oxford Nanopore reports 28% revenue growth in first half of 2025

LONDON - Oxford Nanopore Technologies plc (LSE:ONT) reported revenue of approximately £105 million for the six months ended June 30, 2025, representing a 28% increase on a constant currency basis compared to the same period last year, according to a company press release.

The molecular sensing technology provider exceeded expectations with 25% reported growth over the £84.1 million recorded in the first half of 2024. The PromethION product range led performance with approximately 59% year-on-year growth.

The company saw strong growth across both its market segments, with Research up 22% and Applied markets (including BioPharma, Clinical and Industrial) increasing 33%. Geographically, the EMEAI and APAC regions each grew more than 30% on a constant currency basis, while the Americas rose 17% despite ongoing uncertainty in the U.S. research environment.

Gross margin for the period is expected to be marginally below the 58.8% reported in the first half of 2024, affected by a non-cash one-off inventory charge and currency headwinds, despite targeted improvement measures and increased capital expenditure purchases by customers.

The company reported a reduction in adjusted EBITDA loss compared to both the previous year and the prior six months, supported by disciplined cost management and gross profit growth.

As of June 30, 2025, Oxford Nanopore maintained approximately £337 million in cash, cash equivalents and other liquid investments, down from £403.8 million at the end of 2024. The company noted improved cash flow conversion driven by its new pricing model and higher proportion of capital expenditure purchases by customers.

The company stated that its full-year guidance remains on track across all metrics. Oxford Nanopore will announce its complete interim results on September 2, 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.